Skip to main content
Plasmapp Co., Ltd. logo

Plasmapp Co., Ltd. — Investor Relations & Filings

Ticker · 405000 ISIN · KR7405000001 KO Manufacturing
Filings indexed 214 across all filing types
Latest filing 2023-11-02 Director's Dealing
Country KR South Korea
Listing KO 405000

About Plasmapp Co., Ltd.

https://plasmapp.com/

Plasmapp Co., Ltd. is a company specializing in plasma engineering technology for the medical sector. Originating from the Korea Advanced Institute of Science and Technology (KAIST), the company develops and manufactures advanced plasma-based solutions. Its core offerings include low-temperature plasma sterilizers, such as the STERLINK series, designed for the rapid and safe sterilization of heat-sensitive medical instruments. In addition to sterilization and disinfection, Plasmapp provides technologies for surface treatment and regenerative activation to enhance the safety and efficacy of medical devices, including implants, aiming to improve infection control and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often filed with the Financial Supervisory Service/DART) to report insider trading or changes in share ownership by company directors and major shareholders. This aligns perfectly with the 'Director's Dealing' (DIRS) category.
2023-11-02 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Plasmapp Co., Ltd.' covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial data, business operations, management discussions, and capital structure information. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial and operational analysis for a period shorter than a full fiscal year. 9M 2023
2023-10-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Lee Jeong Hoon) regarding their holdings in Plasmapp Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2023-10-27 Korean
전환가액의조정(제1회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (제1회차 전환가액의 조정). It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-10-23 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to specific executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation for directors/employees is classified under 'Share Issue/Capital Change' (SHA) in the provided taxonomy, as it relates to the potential future issuance of shares.
2023-10-12 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory filing regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company Plasmapp. It details the contract amount, the counterparty (QMED Corporation), the contract period, and the nature of the supply. In the context of financial filings, announcements of specific commercial contracts or supply agreements that do not fit into other specific categories like M&A or capital changes are classified as general regulatory filings (RNS).
2023-10-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.